NCT02841761View on ClinicalTrials.gov

A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

September 1, 2016

Study Completion Date

October 1, 2016

Conditions
Healthy Subjects
Interventions
DRUG

Midalozam

Syrup for oral use

DRUG

Aprocitentan

Capsules for oral use

Trial Locations (1)

07103

Investigator Site, Newark

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY